CS MEDICA | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
CS MEDICA

BRIEF

published on 11/04/2024 at 09:06, 17 days 4 hours ago

CS MEDICA A/S Positioned for Strong Growth in Alternative Medicine Market

Market Growth Alternative Medicine CS MEDICA CANNASEN® CBD-infused Devices
BRIEF

published on 11/04/2024 at 09:06, 17 days 4 hours ago

CS MEDICA A/S se positionne pour une forte croissance sur le marché de la médecine alternative

Croissance Du Marché CS MEDICA CANNASEN® Appareils Infusés Au CBD Médecine Alternative
PRESS RELEASE

published on 11/04/2024 at 09:01, 17 days 4 hours ago

Original-Research: CS MEDICA A/S (von NuWays AG): Buy
CS MEDICA A/S, a Danish Med-Tech company, revolutionizes alternative medicine with CBD-infused medical devices for autoimmune and stress-related conditions. Positioned for strong top-line growth

Alternative Medicine CS MEDICA A/S CBD-infused Medical Devices Top-line Growth Danish Med-Tech Company
BRIEF

published on 07/01/2024 at 12:07, 4 months 20 days ago

CS MEDICA Stock Now Also Traded on XETRA

Liquidity Trading XETRA CS MEDICA A/S Hauck Aufhäuser Lampe
BRIEF

published on 07/01/2024 at 12:07, 4 months 20 days ago

L'action CS MEDICA est désormais également négociée sur XETRA

Liquidité XETRA Commerce CS MEDICA A/S Lampe Aufhäuser Hauck
PRESS RELEASE

published on 07/01/2024 at 12:02, 4 months 20 days ago

CS MEDICA Stock Now Also Traded on XETRA
CS MEDICA A/S shares now available for trading on XETRA, offering increased liquidity and trading opportunities. Private bank ensures liquidity provision as Designated Sponsor

Liquidity Trading XETRA CS MEDICA A/S Designated Sponsor
BRIEF

published on 06/17/2024 at 15:40, 5 months 3 days ago

CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel

Regulatory Approval CS MEDICA CBD-infused Medical Devices Israel CANNASEN®
BRIEF

published on 06/17/2024 at 15:40, 5 months 3 days ago

Le groupe CS MEDICA obtient l'enregistrement complet des dispositifs médicaux infusés au CBD CANNASEN® en Israël

L'approbation Réglementaire CS MEDICA Israel CANNASEN® Dispositifs Médicaux Infusés Au CBD
PRESS RELEASE

published on 06/17/2024 at 15:35, 5 months 3 days ago

EQS-Adhoc: CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel
CS MEDICA Group achieves complete registration of CANNASEN® CBD-infused medical devices in Israel, marking a significant milestone in expanding its global footprint and offering innovation in substance-based medical devices containing bioactive CBD

Regulatory Approval CBD-infused Medical Devices Israel CANNASEN® CS MEDICA Group
BRIEF

published on 06/10/2024 at 14:11, 5 months 10 days ago

CS MEDICA A/S Plans Spin-Off and Listing of CANNORDIC A/S

IPO Spin-off CS MEDICA CANNORDIC CBD

Accesswire

Published on 11/21/2024 at 12:00, 1 hour 6 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 1 hour 6 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 36 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 3 hours 3 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 3 hours 6 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 31 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 51 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 6 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 36 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 8 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 8 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 8 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 59 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 46 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE